Loading
A phase 2 trial of tislelizumab in colorectal cancer, run by brenner baruch, now recruiting.
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer. is a phase 2, randomised interventional study registered as NCT06940388 by brenner baruch, with a registry enrolment figure of 134 participants, started 2025-07-23 and due to reach its primary completion in 2029-08. Interventions recorded: Tislelizumab; Total neoadjuvant therapy (TNT). Conditions listed: Locally Advanced Rectal Cancer (LARC). Primary outcome: 3-year total mesorectal excision (TME) free survival rates. Colorectal eligibility wording from the registry: "* No prior chemotherapy, immunotherapy, radiotherapy or surgery for rectal cancer". Sites: Germany, Israel. No results are recorded here; the registry entry is the source.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Tislelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.